| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. (AUPH) has 8 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. AUPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 13.04M | $214.71M | +814.6K | |
| CEO | 1.85M | $30.37M | - | |
| COO | 695.8K | $11.45M | - | |
| CFO | 626.4K | $10.31M | - | |
| VP | 557.4K | $9.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2021 | Donley Matthew Maxwell54 | Ex VP, Intern'l Operations | Buy | 9,900 | $10.07 | $99,738.54 | New | +39.7% | -14.7% | |
| May 11, 2021 | Greenleaf Peter49 | Chief Executive Officer | Buy | 5,125 | $10.71 | $54,891.07 | +27.3% | +39.7% | -14.7% | |
| May 11, 2021 | Miller Joseph M50 | Chief Financial Officer | Buy | 1,000 | $9.74 | $9,740.00 | New | +39.7% | -14.7% | |
| May 11, 2021 | Leversage Jill | Director | Buy | 2,500 | $10.96 | $27,389.25 | +208.3% | +39.7% | -14.7% | |
| Mar 12, 2021 | Solomons Neil82 | Chief Medical Officer | Sale+OE | 40,000 | $13.49 | $539,600.00 | -17.6% | -8.0% | -22.8% | |
| Mar 5, 2021 | Milne George M Jr59 | Director | Buy | 5,000 | $13.00 | $65,000.00 | +12.5% | -2.2% | -19.2% | |
| Jan 29, 2021 | Leversage Jill | Director | Buy | 1,600 | $16.03 | $25,648.00 | New | - | - | |
| Jan 28, 2021 | Robertson Stephen P. | EVP, General Counsel | Buy | 900 | $16.14 | $14,526.00 | +49.5% | - | - |